-
Berkshire Hathaway Q1 Earnings, Q1 Book Value Estimates
Post on 4/2/19
-
Ironwood Pharmaceuticals Completes Separation of Cyclerion Therapeutics
Post on 4/1/19
-
Paratek Pharmaceuticals Receives American Chemical Society 2019 Heroes of Chemistry Award
Post on 4/1/19
-
Candel Therapeutics Completes $22.5 Million Series C
Post on 4/1/19
-
X4 Pharmaceuticals Provides Business and Clinical Development Update
Post on 4/1/19
-
Novartis to Acquire IFM Tre
Post on 4/1/19
-
Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare
Post on 4/1/19
-
SpringWorks Therapeutics Completes $125 Million Series B Financing
Post on 4/1/19
-
Thoughts On A Post-Merger Bristol-Myers Squibb: Scaling From Celgene To Buy BMS
Post on 4/1/19
-
Tufts Health Plan Earns Highest Rating Possible in 2019 Corporate Equality Index
Post on 3/31/19
-
ImmuCell Corp. Closes $9 Million Public Offering of Common Stock
Post on 3/31/19
-
Chiasma Prices Underwritten Public Offering of $30.0 Million of Common Stock
Post on 3/31/19
-
Aileron Therapeutics Announces Pricing of $26M Private Placement
Post on 3/31/19
-
Why Biogen's Alzheimer's Drug Failure May Have a Silver Lining
Post on 3/29/19
-
Is Biogen a Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger on the Rocks?
Post on 3/29/19
-
Blueprint Medicines Prices Public Offering of Shares of Common Stock
Post on 3/28/19
-
Chiasma Announces Proposed Offering of Common Stock
Post on 3/28/19
-
EyePoint Pharmaceuticals Prices Public Offering of Common Stock
Post on 3/28/19
-
Corbus Pharmaceuticals Provides Management Team Updates
Post on 3/28/19
-
Mitsubishi Tanabe Pharma America Announces Collaboration With Massachusetts General Hospital On ALS Biomarker Study
Post on 3/28/19
-
Centene's New Hampshire Subsidiary Wins Medicaid Contract
Post on 3/28/19
-
Hyalex Orthopaedics, Synthetic Cartilage Company, Adds New Funding
Post on 3/28/19
-
swyMed Partners with Life Image
Post on 3/28/19
-
Thermo Fisher Makes Move In Gene Therapy Space To Help Services Business Unit
Post on 3/28/19
-
ImmuCell Corp. Prices $9.0 Million Public Offering of Common Stock
Post on 3/27/19